Back to search

Article

Therapeutic Potential of PRMT1 as a Critical Survival Dependency Target in Multiple Myeloma

2025-02-01

Abstract excerpt

Multiple myeloma (MM) is a neoplasm of antibody-producing plasma cells and is the second most prevalent hematological malignancy worldwide. Development of drug resistance and disease relapse significantly impede the success of MM treatment, highlighting the critical need to discover novel therapeutic targets. In a custom CRISPR/Cas9 screen targeting 197 DNA damage response-related genes, Protein Arginine N-Methylt...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
037b2849-0724-5851-b04a-d762bd9fd6df
DOI
10.1101/2025.01.29.635603
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapeutic Potential of PRMT1 as a Critical Survival Dependency Target in Multiple MyelomaDOI 10.1101/2025.01.29.635603
Select a neighboring publication to make it the new centre.